Biohaven Licenses Taldefgrobep Alfa, a Phase 3-Ready Anti-Myostatin Adnectin for Spinal Muscular Atrophy (SMA),...
Biohaven Pharmaceutical Holding Company Ltd. announced that it entered into a worldwide license agreement with...
Tesis Biosciences Acquires Genome Explorations to Accelerate Clinical Research and Product Development for Chronic...
Tesis Biosciences, the leader in targeted genetic sequencing, has acquired Genome Explorations, a premier research...
Velocity Clinical Research makes tech investments to strengthen patient and client engagement in clinical...
Velocity Clinical Research, the largest fully integrated clinical site organization, announces three key tech investments...
Thermo Fisher Scientific Partners with Medidata Acorn AI to Optimize Clinical Research Site Selection...
Thermo Fisher Scientific Inc., the world leader in serving science, announced a multiyear partnership with...
Valneva Announces Initiation of Adolescent Phase 3 Trial for its Single-Shot Chikungunya Vaccine Candidate
Valneva SE, a specialty vaccine company, announced the initiation of a Phase 3 trial in...
ZS and IgniteData partner to transform patient data automation for clinical trials
The global professional services firm ZS announced today that it has entered into a strategic...
Pfizer and BioNTech Initiate Study to Evaluate Omicron-Based COVID-19 Vaccine in Adults 18 to...
Pfizer Inc. and BioNTech SE announced the initiation of a clinical study to evaluate the...
Pfizer Shares In Vitro Efficacy of Novel COVID-19 Oral Treatment Against Omicron Variant
Pfizer Inc. shared results from multiple studies demonstrating that the in vitro efficacy of nirmatrelvir,...
Catalent Launches New Xpress Pharmaceutics Service to Expedite Development of Oral Drugs for Adaptive...
Catalent, the global leader in enabling biopharma, cell, gene, and consumer health partners to optimize...
Immune Biosolutions reports that its lead immunotherapy product IBIO123 neutralizes 100% of the SARS-CoV-2,...
Immune Biosolutions Inc., a clinical-stage company, is pleased to announce that its leading biological drug...